Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1
Related Experiment Video
Updated: Aug 17, 2026
Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
Hua Zhu1, Chuanxi Cai, Jianwen Chen
1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Dantun Road 15, Chaoyang District, Beijing 100101, China.
Abstract:
Caveolin-1, the principal component of caveolae, is a 21-24 kDa integral membrane protein. The interaction of the caveolin-1 scaffolding domain with signaling molecules can functionally inhibit the activity of these signaling proteins. Little is known about how caveolin-1 influences the expression of P-glycoprotein (P-gp), an ABC transporter encoded by multi-drug resistance (MDR1) gene. To elucidate the possible mechanism between caveolin-1 and P-gp expression, in the present study, we overexpressed caveolin-1 in the Hs578T/Dox breast adenocarcinoma cells, a multidrug resistant line, and then selected single clone cells highly expressing caveolin-1 level. Both Western blot and confocal microscopy analyses showed that caveolin-1 was markedly overexpressed in the transfectants, while P-gp protein was almost abolished. Reverse transcription polymerase chain reaction also showed that the expression of P-gp mRNA was significantly suppressed in the transfectants. It was confirmed further by Northern blot analysis. Moreover, through measuring the changes of drug resistance and P-gp transport activity in the transfectants, we found that overexpression of caveolin-1 reversed drug resistance of transfectants and lowered their P-gp transport activity to the level of Hs578T/S. Taken together, our results indicate that such suppression of P-gp in the transfectants overexpressing caveolin-1 may occur at the transcriptional level.
Insights
Overexpressing caveolin-1 in breast cancer cells significantly reduces P-glycoprotein (P-gp) expression and reverses multidrug resistance. This suggests caveolin-1 regulates P-gp at the transcriptional level.
Area of Science:
- Molecular biology
- Cell biology
- Cancer research
Background:
- Caveolin-1 is a key component of caveolae, involved in cellular signaling.
- The role of caveolin-1 in regulating P-glycoprotein (P-gp) expression is not well understood.
- P-glycoprotein (P-gp), encoded by the MDR1 gene, is an ABC transporter associated with multidrug resistance.
Purpose of the Study:
- To investigate the mechanism by which caveolin-1 influences P-glycoprotein (P-gp) expression.
- To determine if caveolin-1 affects the multidrug resistance phenotype in breast cancer cells.
Main Methods:
- Overexpression of caveolin-1 in Hs578T/Dox multidrug-resistant breast adenocarcinoma cells.
- Western blot and confocal microscopy to assess protein levels of caveolin-1 and P-gp.
- Reverse transcription polymerase chain reaction (RT-PCR) and Northern blot analysis to evaluate P-gp mRNA expression.
- Measurement of drug resistance and P-gp transport activity.
Main Results:
- Caveolin-1 was successfully overexpressed in transfectant cells.
- P-gp protein and mRNA expression were significantly suppressed in cells overexpressing caveolin-1.
- Overexpression of caveolin-1 reversed drug resistance and decreased P-gp transport activity.
- Suppression of P-gp appears to occur at the transcriptional level.
Conclusions:
- Caveolin-1 overexpression leads to a significant reduction in P-glycoprotein (P-gp) expression.
- The regulation of P-gp by caveolin-1 occurs at the transcriptional level.
- Targeting caveolin-1 may offer a strategy to overcome multidrug resistance in breast cancer.
More Related Videos
Related Concept Videos
01:58Cell Specific Gene Expression
02:23Abnormal Proliferation